<<

10314 Federal Register / Vol. 75, No. 43 / Friday, March 5, 2010 / Notices

that the company’s registration is Schedule (DEA) to be registered as a bulk consistent with the public interest. The manufacturer of the basic classes of investigation has included inspection (9050) ...... II controlled substances listed in and testing of the company’s physical (9143) ...... II schedules I and II: security systems, verification of the (9150) ...... II Benzoylecgonine (9180) ...... II Drug Schedule company’s compliance with state and (9190) ...... II local laws, and a review of the (9193) ...... II company’s background and history. (7370) ..... I (9226) ...... II 3,4- I Therefore, pursuant to 21 U.S.C. 823, Meperidine (9230) ...... II Methylenedioxymethamphetam- and in accordance with 21 CFR 1301.33, Meperidine intermediate-A (9232) II ine (MDMA) (7405). the above named company is granted Meperidine intermediate-B (9233) II (9041) ...... II registration as a bulk manufacturer of (9250) ...... II Oxycodone (9143) ...... II the basic classes of controlled Methadone intermediate (9254) ... II Hydrocodone (9193) ...... II , bulk, (non- II Methadone (9250) ...... II substances listed. dosage forms) (9273). Dextropropoxyphene, bulk (non- II (9300) ...... II Dated: February 26, 2010. dosage forms) (9273). (9333) ...... II Joseph T. Rannazzisi, Morphine (9300) ...... II Levo- (9648) .. II Deputy Assistant Administrator, Office of (9652) ...... II Diversion Control, Drug Enforcement The company plans to manufacture Administration. The company plans to manufacture the listed controlled substances as bulk [FR Doc. 2010–4728 Filed 3–4–10; 8:45 am] small quantities of the listed controlled reagents for use in drug abuse testing. BILLING CODE 4410–09–P substances to produce isotope labeled No comments or objections have been standards for drug testing and analysis. received. DEA has considered the No comments or objections have been factors in 21 USC 823(a) and determined DEPARTMENT OF JUSTICE received. DEA has considered the that the registration of Lin Zhi Drug Enforcement Administration factors in 21 U.S.C. 823(a) and International Inc., to manufacture the determined that the registration of listed basic classes of controlled Manufacturer of Controlled Aldrich Chemical Company Inc., to substances is consistent with the public Substances; Notice of Registration manufacture the listed basic classes of interest at this time. DEA has controlled substances is consistent with investigated Lin Zhi International Inc., By Notice dated October 20, 2009, and the public interest at this time. DEA has to ensure that the company’s published in the Federal Register on investigated Aldrich Chemical Company registration is consistent with the public October 28, 2009, (74 FR 55588), Inc., to ensure that the company’s interest. The investigation has included Aldrich Chemical Company, Inc., DBA registration is consistent with the public inspection and testing of the company’s Isotec, 3858 Benner Road, Miamisburg, interest. The investigation has included physical security systems, verification Ohio 45342–4304, made application by inspection and testing of the company’s of the company’s compliance with state renewal to the Drug Enforcement physical security systems, verification and local laws, and a review of the Administration (DEA) to be registered as of the company’s compliance with state company’s background and history. a bulk manufacturer of the basic classes and local laws, and a review of the Therefore, pursuant to 21 USC 823, and of controlled substances listed in company’s background and history. in accordance with 21 CFR 1301.33, the schedules I and II: Therefore, pursuant to 21 U.S.C. 823, above named company is granted and in accordance with 21 CFR 1301.33, registration as a bulk manufacturer of Drug Schedule the above named company is granted the basic classes of controlled Gamma Hydroxybutyric Acid I registration as a bulk manufacturer of substances listed. (2010). the basic classes of controlled Dated: February 26, 2010. Methaqualone (2565) ...... I substances listed. Joseph T. Rannazzisi, (7260) ...... I Dated: February 26, 2010. Tetrahydrocannabinols (7370) ..... I Deputy Assistant Administrator, Office of 2,5-Dimethoxyamphetamine I Joseph T. Rannazzisi, Diversion Control, Drug Enforcement (7396). Deputy Assistant Administrator, Office of Administration. Psilocyn (7438) ...... I Diversion Control, Drug Enforcement [FR Doc. 2010–4719 Filed 3–4–10; 8:45 am] (9313) ...... I Administration. BILLING CODE 4410–09–P (9601) ...... I [FR Doc. 2010–4723 Filed 3–4–10; 8:45 am] Alphacetylmethadol except levo– I BILLING CODE 4410–09–P alphacetylmethadol (9603). DEPARTMENT OF JUSTICE (9635) ...... I (9636) ...... I Drug Enforcement Administration 3-Methylfentanyl (9813) ...... I DEPARTMENT OF JUSTICE Amphetamine (1100) ...... II Drug Enforcement Administration Manufacturer of Controlled Methamphetamine (1105) ...... II Substances; Notice of Registration Methylphenidate (1724) ...... II Amobarbital (2125) ...... II Manufacturer of Controlled Substances; Notice of Registration By Notice dated September 17, 2009, (2270) ...... II and published in the Federal Register Secobarbital (2315) ...... II By Notice dated October 16, 2009, and on September 25, 2009, (74 FR 49020), 1-Phenylcyclohexylamine (7460) II published in the Federal Register on Cerilliant Corporation, 811 Paloma (7471) ...... II Phenylacetone (8501) ...... II October 28, 2009, (74 FR 55586), Lin Drive, Suite A, Round Rock, Texas 1- II Zhi International Inc., 687 North 78665–2402, made application by Piperidinocyclohexanecarbonitr- Pastoria Avenue, Sunnyvale, California renewal to the Drug Enforcement ile (8603). 94085, made application by renewal to Administration (DEA) to be registered as Cocaine (9041) ...... II the Drug Enforcement Administration a bulk manufacturer of the basic classes

VerDate Nov<24>2008 14:45 Mar 04, 2010 Jkt 220001 PO 00000 Frm 00111 Fmt 4703 Sfmt 4703 E:\FR\FM\05MRN1.SGM 05MRN1 erowe on DSK5CLS3C1PROD with NOTICES